37 results on '"Caporali, Roberto"'
Search Results
2. The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus
3. Deciphering the clinical significance of longitudinal antiphospholipid antibody titers
4. Start RA treatment – Biologics or JAK-inhibitors?
5. Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission
6. Caffeine and rheumatoid arthritis: A complicated relationship
7. Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission
8. Abatacept as a first-line biological therapy
9. Myocardial involvement in anti-phospholipid syndrome: Beyond acute myocardial infarction
10. Epigenetics, pregnancy and autoimmune rheumatic diseases
11. Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?
12. Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors
13. COVID-19 infection and rheumatoid arthritis: Faraway, so close!
14. Biosimilars vs originators: Are they the same?
15. Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies
16. Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis
17. The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts
18. TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?
19. The management of first-line biologic therapy failures in rheumatoid arthritis: Current practice and future perspectives
20. How I treat idiopathic patients with inflammatory myopathies in the clinical practice
21. Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies
22. Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: Could it be the first step of the treatment?
23. Long-term safety of abatacept in patients with rheumatoid arthritis
24. WITHDRAWN: Abatacept as a first-line biological therapy
25. Early treatment in early undifferentiated arthritis
26. Switching rheumatoid arthritis treatments: An update
27. The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases
28. Switching TNF-alpha antagonists in rheumatoid arthritis: The experience of the LORHEN registry
29. Tumour necrosis factor antagonist therapy and cancer development: Analysis of the LORHEN registry
30. Long term treatment of rheumatoid arthritis with rituximab
31. Predicting response to anti-TNF treatment in rheumatoid arthritis patients
32. Serious infections during anti-TNFα treatment in rheumatoid arthritis patients
33. Anti-TNFα therapy in a cohort of rheumatoid arthritis patients: Clinical outcomes
34. Treatment of rheumatoid arthritis with anti-TNF-alpha agents: A reappraisal
35. DMARDS and infections in rheumatoid arthritis
36. Treatment of rheumatic diseases in patients with HCV and HIV infection
37. B cells in rheumatoid arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.